Not Yet Recruiting
VERIFY: Vedolizumab for the Prevention of Immune Checkpoint Inhibitor Related Diarrhea or Colitis in Patients With Cancer
NCT06337695
- Conditions
- Cancer, Cancer Metastatic, Neoplasm Metastasis, +4 more
- Locations
-
Not specified